McKesson Corporation (NYSE:MCK) is included among the 14 Best Pharma Dividend Stocks to Buy in 2026. On December 10, Deutsche ...

If you are wondering whether McKesson still looks attractive after its strong run, or whether much of the potential upside is ...

McKesson saw strong 2025 growth from GLP-1 tailwinds, but fading momentum, weak margins, and a 21x forward P/E show ...

WisdomTree U.S. Quality Dividend Growth Fund ETF's 1.3% yield and 4.9% 5-year dividend growth lag income-focused peers. See ...

Discover the top 3 undervalued Health Care Providers & Services stocks for Wednesday, December 31 based on AAII’s Stock ...

McKesson trades at $825.38 and has moved in lockstep with the market. Its shares have returned 14.5% over the last six months ...

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a ...

In ordering the additional discovery, U.S. District Judge Nina Gershon pointed out that McKesson—represented by Covington & Burling—had told U.S. Magistrate Judge Steven Tiscione “in the strongest ...

Mizuho Securities analyst Steven Valiquette maintained a Hold rating on McKesson yesterday and set a price target of $880.00. The company’s shares closed yesterday at $818.40.